Buglioni S - Search Results

1

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy.

Ercolani C, Di Benedetto A, Terrenato I, Pizzuti L, Di Lauro L, Sergi D, Sperati F, Buglioni S, Ramieri MT, Mentuccia L, Gamucci T, Perracchio L, Pescarmona E, Mottolese M, Barba M, Vici P, De Maria R, Maugeri-Saccà M. Ercolani C, et al. Among authors: buglioni s. Cancer Biol Ther. 2017 May 4;18(5):339-346. doi: 10.1080/15384047.2017.1312230. Epub 2017 Apr 7. Cancer Biol Ther. 2017. PMID: 28387539 Free PMC article.

2

An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples.

Bironzo P, Pepe F, Russo G, Pisapia P, Gragnano G, Aquino G, Bessi S, Buglioni S, Bartoccini F, Ferrero G, Bresciani MA, Francia di Celle P, Sibona F, Giusti A, Movilia A, Farioli RM, Santoro A, Salemi D, Scarpino S, Galafate D, Tommasi S, Lacalamita R, Seminati D, Sajjadi E, Novello S, Pagni F, Troncone G, Malapelle U. Bironzo P, et al. Among authors: buglioni s. Diagnostics (Basel). 2023 Feb 8;13(4):629. doi: 10.3390/diagnostics13040629. Diagnostics (Basel). 2023. PMID: 36832117 Free PMC article.

3

Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.

Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, Zupi G, Mottolese M. Buglioni S, et al. Int J Cancer. 1999 Dec 22;84(6):545-52. doi: 10.1002/(sici)1097-0215(19991222)84:6<545::aid-ijc1>3.0.co;2-2. Int J Cancer. 1999. PMID: 10567896

4

Prognostic relevance of altered Fas (CD95)-system in human breast cancer.

Mottolese M, Buglioni S, Bracalenti C, Cardarelli MA, Ciabocco L, Giannarelli D, Botti C, Natali PG, Concetti A, Venanzi FM. Mottolese M, et al. Among authors: buglioni s. Int J Cancer. 2000 Mar 20;89(2):127-32. doi: 10.1002/(sici)1097-0215(20000320)89:2<127::aid-ijc5>3.0.co;2-4. Int J Cancer. 2000. PMID: 10754489

5

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy.

Mottolese M, Benevolo M, Del Monte G, Buglioni S, Papaldo P, Nisticò C, Di Filippo F, Vasselli S, Vici P, Botti C. Mottolese M, et al. Among authors: buglioni s. J Cancer Res Clin Oncol. 2000 Dec;126(12):722-9. doi: 10.1007/pl00008478. J Cancer Res Clin Oncol. 2000. PMID: 11153146

6

c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Biroccio A, Benassi B, D'Agnano I, D'Angelo C, Buglioni S, Mottolese M, Ricciotti A, Citro G, Cosimelli M, Ramsay RG, Calabretta B, Zupi G. Biroccio A, et al. Among authors: buglioni s. Am J Pathol. 2001 Apr;158(4):1289-99. doi: 10.1016/S0002-9440(10)64080-1. Am J Pathol. 2001. PMID: 11290547 Free PMC article.

7

Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancer.

Di Modugno F, Buglioni S, Mottolese M, Bello DD, Cascioli S, Chersi A, Santoni A, Nisticò P. Di Modugno F, et al. Among authors: buglioni s. J Immunother. 2001 May-Jun;24(3):221-31. J Immunother. 2001. PMID: 11394499

8

Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer.

Di Modugno F, Buglioni S, Mottolese M, Del Bello D, Cascioli S, Chersi A, Santoni A, Nisticò P. Di Modugno F, et al. Among authors: buglioni s. J Immunother (1991). 2001 May;24(3):221-231. J Immunother (1991). 2001. PMID: 11395637

9

p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.

Buglioni S, D'Agnano I, Vasselli S, Perrone Donnorso R, D'Angelo C, Brenna A, Benevolo M, Cosimelli M, Zupi G, Mottolese M. Buglioni S, et al. Am J Clin Pathol. 2001 Sep;116(3):360-8. doi: 10.1309/V7UW-UT2E-JVYH-DGWK. Am J Clin Pathol. 2001. PMID: 11554164

10

Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.

Greco C, Alvino S, Buglioni S, Assisi D, Lapenta R, Grassi A, Stigliano V, Mottolese M, Casale V. Greco C, et al. Among authors: buglioni s. Anticancer Res. 2001 Sep-Oct;21(5):3185-92. Anticancer Res. 2001. PMID: 11848471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters